Key Insights

The European Continuous Glucose Monitoring (CGM) market is experiencing robust growth, projected to reach €2.04 billion in 2025 and maintain a Compound Annual Growth Rate (CAGR) of 11.33% from 2025 to 2033. This expansion is fueled by several key factors. The increasing prevalence of diabetes, particularly Type 1 and Type 2, across major European nations like Germany, France, and the UK, forms the primary driver. Technological advancements leading to smaller, more accurate, and user-friendly CGM devices are also significantly contributing to market growth. Furthermore, rising healthcare expenditure and increased patient awareness regarding the benefits of continuous glucose monitoring, such as improved glycemic control and reduced risk of complications, are bolstering market adoption. The market's segmentation into sensors and durables reflects the diverse components driving revenue. While sensors represent a larger share due to their recurring consumption, the durables segment experiences growth driven by initial device purchases. Competition among leading players like Medtronic, Abbott, Dexcom, Senseonics, and Ascensia drives innovation and market penetration, leading to a more diversified landscape and improved device affordability.

The market's regional distribution within Europe shows strong performance across major economies. Germany, France, Italy, and the United Kingdom represent significant market shares, driven by well-established healthcare infrastructures and higher diabetes prevalence rates. However, growth opportunities exist in other European countries as awareness increases and access to advanced medical technology improves. The market is expected to witness further consolidation with mergers and acquisitions, along with a focus on developing integrated CGM systems offering advanced analytics and remote monitoring capabilities. The ongoing research and development efforts to enhance the accuracy, longevity, and usability of CGM devices will further contribute to market expansion over the forecast period. The integration of CGM data with other health monitoring devices and applications will also become increasingly significant, opening up new avenues for growth and market diversification.

Europe Continuous Glucose Monitoring (CGM) Market Report: 2019-2033

This comprehensive report provides a detailed analysis of the Europe Continuous Glucose Monitoring (CGM) market, encompassing market dynamics, growth trends, regional performance, product landscape, challenges, opportunities, and key players. The study period covers 2019-2033, with 2025 as the base year and a forecast period of 2025-2033. The report offers valuable insights for industry professionals, investors, and stakeholders seeking to understand and navigate this rapidly evolving market. The market is segmented into Continuous Glucose Monitoring: Sensors and Durables, providing granular analysis for informed decision-making. The total market size in 2025 is estimated at xx Million units.

Europe Continuous Glucose Monitoring Market Dynamics & Structure

The European CGM market is characterized by moderate concentration, with key players like Medtronic, Abbott, Dexcom, Senseonics, and Ascensia holding significant market share. However, the market exhibits strong potential for new entrants due to technological advancements and increasing demand. The market's structure is influenced by several factors:

• Market Concentration: Medtronic and Abbott currently dominate, holding approximately xx% and xx% market share respectively in 2025. Other players, including Dexcom and Senseonics, collectively account for xx%, leaving xx% for other companies.
• Technological Innovation: Continuous innovation in sensor technology, data analytics, and integration with mobile applications is driving market growth. Miniaturization, improved accuracy, and longer wear times are key innovation drivers.
• Regulatory Frameworks: Stringent regulatory approvals (e.g., CE Mark) and reimbursement policies influence market access and adoption. Harmonization of regulations across EU member states could further boost market growth.
• Competitive Product Substitutes: Traditional blood glucose monitoring systems remain a competitive alternative, though CGM systems are gaining preference due to their convenience and continuous data provision.
• End-User Demographics: The growing prevalence of diabetes, particularly type 1 and type 2, coupled with increasing awareness about CGM benefits, fuels market expansion. An aging population also contributes to market growth.
• M&A Trends: Consolidation activity is moderate, with strategic partnerships and collaborations becoming more prevalent than large-scale mergers and acquisitions. The number of M&A deals in the last 5 years was approximately xx.

Europe Continuous Glucose Monitoring Market Growth Trends & Insights

The European CGM market is experiencing robust growth, driven by increasing diabetes prevalence, technological advancements, and improving healthcare infrastructure. The market size expanded from xx Million units in 2019 to xx Million units in 2024, registering a CAGR of xx%. This growth trajectory is projected to continue, with the market expected to reach xx Million units by 2033, exhibiting a CAGR of xx% during the forecast period (2025-2033). This expansion reflects rising adoption rates among patients, particularly those with type 1 diabetes, and improved patient outcomes attributed to continuous glucose monitoring. Technological disruptions, including the introduction of less invasive sensors and improved data integration capabilities, are also fueling market expansion. Consumer behavior shifts, such as increased preference for convenient and user-friendly devices, along with the rising affordability of CGM systems, are further contributing to market growth.

Dominant Regions, Countries, or Segments in Europe Continuous Glucose Monitoring Market

Germany, the UK, and France are the leading markets within Europe, collectively accounting for approximately xx% of the total market in 2025. High diabetes prevalence, advanced healthcare systems, and favorable reimbursement policies are key factors driving market dominance in these countries.

• Germany: Strong healthcare infrastructure, high diabetes prevalence, and proactive government initiatives supporting diabetes management contribute to Germany's leading position.
• United Kingdom: A sizeable diabetic population and well-established healthcare system fuel market growth.
• France: Growing awareness about CGM benefits and increasing healthcare expenditure contribute to France's position as a significant market.

Within the CGM segments, the Sensors segment holds a larger market share (approximately xx% in 2025) compared to the Durables segment (xx%), driven by the recurring nature of sensor replacements. The Sensors segment is projected to witness faster growth due to technological innovations leading to more accurate and comfortable sensors.

Europe Continuous Glucose Monitoring Market Product Landscape

The European CGM market offers a diverse range of products, with key players continuously innovating to improve accuracy, ease of use, and data integration capabilities. Recent advancements include smaller, less invasive sensors, extended wear times, and seamless integration with smartphone applications and cloud-based platforms. Unique selling propositions often focus on improved accuracy, reduced calibration requirements, and enhanced user experience. The market also observes a trend towards integrated systems offering comprehensive diabetes management capabilities beyond simple glucose monitoring.

Key Drivers, Barriers & Challenges in Europe Continuous Glucose Monitoring Market

Key Drivers:

• Rising Diabetes Prevalence: The escalating incidence of type 1 and type 2 diabetes across Europe is a significant driver.
• Technological Advancements: Innovations in sensor technology, data analysis, and user interfaces are making CGM systems more accessible and user-friendly.
• Improved Healthcare Infrastructure: Enhanced access to healthcare services and growing insurance coverage for CGM devices are boosting market growth.

Key Barriers and Challenges:

• High Cost of Devices: The relatively high cost of CGM systems remains a barrier to wider adoption, particularly for patients with limited financial resources.
• Reimbursement Challenges: Variations in reimbursement policies across European countries hinder market penetration.
• Supply Chain Disruptions: Global supply chain issues can impact the availability and pricing of CGM systems.

Emerging Opportunities in Europe Continuous Glucose Monitoring Market

• Expansion into Untapped Markets: Focus on increasing market penetration in countries with lower CGM adoption rates.
• Development of Innovative Applications: Integrating CGM data with other health monitoring devices to provide a holistic view of patient health.
• Personalized Diabetes Management: Developing algorithms and analytical tools that provide personalized recommendations based on individual patient data.

Growth Accelerators in the Europe Continuous Glucose Monitoring Market Industry

Technological breakthroughs in sensor miniaturization, data analytics, and integration with smart devices are driving long-term growth. Strategic partnerships between CGM manufacturers and healthcare providers are also accelerating market expansion by enhancing access and improving patient outcomes. Moreover, expansion into untapped markets and the development of new applications for CGM technology will fuel future growth.

Key Players Shaping the Europe Continuous Glucose Monitoring Market Market

• Medtronic
• Abbott
• Other Company Share Analyse
• Dexcom
• Senseonics
• Ascensia

Notable Milestones in Europe Continuous Glucose Monitoring Market Sector

• October 2023: Medtronic introduces Simplera, a next-generation CGM system for individuals with diabetes aged 2 and above. This launch significantly expands the addressable market for Medtronic’s CGM devices.
• June 2022: Ascensia Diabetes Care’s partner, Senseonics Holdings, Inc., receives CE Mark approval for the Eversense E3 CGM System, facilitating its widespread use in the EU. This approval opens up a large and previously untapped market for Senseonics.

In-Depth Europe Continuous Glucose Monitoring Market Market Outlook

The European CGM market is poised for sustained growth, driven by technological advancements, increased diabetes prevalence, and growing awareness of the benefits of continuous glucose monitoring. Strategic partnerships, product innovation, and expanding market penetration in underserved regions will further fuel market expansion. The long-term outlook is highly positive, with significant opportunities for both established players and new entrants in this dynamic market.

Europe Continuous Glucose Monitoring Market Segmentation

• 1. Continuous Glucose Monitoring
  • 1.1. Sensors
  • 1.2. Durables

Europe Continuous Glucose Monitoring Market Segmentation By Geography

• 1. France
• 2. Germany
• 3. Italy
• 4. Spain
• 5. Russia
• 6. United Kingdom
• 7. Rest of Europe